Autor: |
Aschner PM; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia; Asociación Colombiana de Diabetes, Bogota, Colombia., Muñoz OM; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia., Girón D; Departamento de Epidemiología y Bioestadística. Pontificia Universidad Javeriana, Bogota, Colombia., García OM; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia., Fernández-Ávila DG; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia., Casas LÁ; Asociación Colombiana de Endocrinología, Universidad del Valle, Cali, Colombia., Bohórquez LF; Federación diabetológica Colombiana, Bogota, Colombia; Universidad Nacional de Colombia, Bogota, Colombia., Arango T CM; Universidad de Antioquia, Medellin, Colombia., Carvajal L; Asociación Colombiana de Diabetes, Bogota, Colombia., Ramírez DA; Universidad Nacional de Colombia, Bogota, Colombia., Sarmiento JG; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia., Colon CA; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia., Correa G NF; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia., Alarcón R P; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia., Bustamante S ÁA; Hospital Universitario San Ignacio, Bogota, Colombia; Pontificia Universidad Javeriana, Bogota, Colombia. |
Abstrakt: |
In Colombia, diabetes mellitus is a public health program for those responsible for creating and implementing strategies for prevention, diagnosis, treatment, and follow-up that are applicable at all care levels, with the objective of establishing early and sustained control of diabetes. A clinical practice guide has been developed following the broad outline of the methodological guide from the Ministry of Health and Social Welfare, with the aim of systematically gathering scientific evidence and formulating recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology. The current document presents in summary form the results of this process, including the recommendations and the considerations taken into account in formulating them. In general terms, what is proposed here is a screening process using the Finnish Diabetes Risk Score questionnaire adapted to the Colombian population, which enables early diagnosis of the illness, and an algorithm for determining initial treatment that can be generalized to most patients with diabetes mellitus type 2 and that is simple to apply in a primary care context. In addition, several recommendations have been made to scale up pharmacological treatment in those patients that do not achieve the objectives or fail to maintain them during initial treatment. These recommendations also take into account the evolution of weight and the individualization of glycemic control goals for special populations. Finally, recommendations have been made for opportune detection of micro- and macrovascular complications of diabetes. |